ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Once-A-Day Pregabalin For Partial Seizures

ClinicalTrials.gov ID: NCT01262677

Public ClinicalTrials.gov record NCT01262677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 27, 2026, 6:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures

Study identification

NCT ID
NCT01262677
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
325 participants

Conditions and interventions

Interventions

  • placebo Drug
  • pregabalin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2011
Primary completion
Jul 30, 2012
Completion
Jul 31, 2012
Last update posted
Jan 24, 2021

2011 – 2012

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
Neurology Clinic, PC Northport Alabama 35476
NEA Baptist Clinic Jonesboro Arkansas 72401
Clinical Trials, Inc. Little Rock Arkansas 72205
Collaborative Neuroscience Network, Inc. Long Beach California 90806
Viking Clinic Research Center Murrieta California 92562
Viking Clinical Research Center Murrieta California 92562
Neurological Research Institute Santa Monica California 90404
Viking Clinical Research Center Temecula California 92591
Sarkis Clinical Trials Gainesville Florida 32607
Optima Neurological Services, LLC Gainesville Florida 32608
Sleep Disorders Center of Georgia - Gainesville Gainesville Georgia 30501
Southern Illinois University School of Medicine Springfield Illinois 62702
VCMA Comprehensive Epilepsy Center Wichita Kansas 67214
Via Christi Research Wichita Kansas 67214
Associates in Neurology, PSC Lexington Kentucky 40513
Mid Atlantic Headache Institute Pikesville Maryland 21208
Asheville Neurology Specialists, PA Asheville North Carolina 28806
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Mark A. Fisher, M.D.- Private Practice Oklahoma City Oklahoma 73112
Sooner Clinical Research Oklahoma City Oklahoma 73112
Veroniqe Sebastian, MD Oklahoma City Oklahoma 73120
Angelique Barreto, MD Oklahoma City Oklahoma 73135
University of Pennsylvania Philadelphia Pennsylvania 19104
FutureSearch Trials of Neurology Austin Texas 78731
Scott and White Healthcare-Office of Sponsored Research Administration Temple Texas 76502
Scott & White Healthcare Temple Texas 76508

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01262677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2021 · Synced Apr 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01262677 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →